|
|
|
Volumn 137, Issue 1, 2002, Pages
|
|
Summaries for patients. Using medication to prevent breast cancer: recommendations from the United States Preventive Services Task Force.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TAMOXIFEN;
BREAST TUMOR;
CHEMOPROPHYLAXIS;
EVIDENCE BASED MEDICINE;
FEMALE;
HUMAN;
NOTE;
PATIENT EDUCATION;
PRIMARY PREVENTION;
RISK ASSESSMENT;
RISK FACTOR;
ANTICARCINOGENIC AGENTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
BREAST NEOPLASMS;
CHEMOPREVENTION;
EVIDENCE-BASED MEDICINE;
FEMALE;
HUMANS;
PRIMARY PREVENTION;
RALOXIFENE;
RISK ASSESSMENT;
RISK FACTORS;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
TAMOXIFEN;
|
|
EID: 18744438002
PISSN: 15393704
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|